ArticleHuman gene therapy2023

Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials.

Jeffrey S Chamberlain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.